Rose Hip and Reduced Urinary Tract Infection

Doses used in studies

mg/day: 1,000 (median 1,000, IQR 1,000–1,000) — 1 study

Time to effect

Median: 2.9 weeks · IQR 2.9 weeks–2.9 weeks · Range 2.9 weeks–2.9 weeks — Reported in 1 of 1 study

1 of 1 paper

The effect of Rosa (L. Rosa canina) on the incidence of urinary tract infection in the puerperium: A randomized placebo-controlled trial.

2017-10-11
RCT · n = 400
Phytotherapy research : PTR 32(1)
- Mahdieh Seifi
- Shamsi Abbasalizadeh
- Sakineh Mohammad-Alizadeh-Charandabi
- Laleh Khodaie
- Mojgan Mirghafourvand

PubMed: 29024081
DOI: 10.1002/ptr.5950

2 Insights on

Reduced Urinary Tract Infection

High evidence
Large Human Trial
Clinical

UTI was significantly lower in the intervention group compared with the control in the follow-ups conducted on the 7th-10th days (odds ratio = 0.22; confidence interval 95% [0.07, 0.67]; p = .006) and 20th day (odds ratio = 0.32; confidence interval 95% [0.14, 0.75]; p = .008).

Effect: Beneficial
Effect size: Large
Significant: Yes
Dose: 500 mg capsules twice daily